Daniel Soffer, MD, FNLA
Disclosures: writing support-Novartis AG-lipid management|Consultant-Ionis (formerly Akcea Therapeutics)-lipid management|industry-sponsored clinical trial participation-Ionis (formerly Akcea Therapeutics)-Lp(a) lowering|industry-sponsored clinical trial participation-Regeneron-lipid management|industry-sponsored clinical trial participation-RegenXBio-lipid management|industry-sponsored clinical trial participation-Astra-Zeneca-lipid management|industry-sponsored clinical trial participation-Amgen Inc-ASCVD risk mgmt - 06/03/2021
No Bio Available.